1 41350sek
0,3 %
Date:2024-11-21Time:17:29:50Latest report:Q3-2024List:Large CapTicker:AZN
Market Cap:2 177 402 msekEnterprise Value:2 445 132 msekNet Sales:51 206 musdEarnings:6 495 musdEmployees:0ISIN:GB0009895292

Ratios

10-year key figure history for AstraZeneca turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for AstraZeneca with index and moving average MA50 and MA200.

Stockprice:1 413,50
MA50:1 546,26
MA200:1 572,40
Price/MA200:-10,7 %
RSI (14):35,6
Price/MA50:-9,2 %

Description

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its sales.

Pharmaceuticals